glp-1 sglt2 Inhibitors and Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application Cardiovascular benefits of SGLT2 inhibitors
Description
Rapid weight loss, however, can also cause bone density loss
Kim S, Han S-Y, Lee J, Kim N-R, Lee BR, Kim H et al (2022) Bifidobacterium longum and galactooligosaccharide improve skin barrier dysfunction and atopic dermatitis-like skin
As for mortality, both SGLT-2 inhibitors and GLP-1RA are similar in reducing both total and CV deaths, but SGLT-2 inhibitors only are superior to DPP-4 inhibitors for both deaths, whereas GLP-1RA are superior to DPP-4 inhibitors for total death, but equal for CV death
[DOI] [PubMed] [Google Scholar] 71
10.1002/jnr.21483 15 BlevinsT.PullmanJ.MalloyJ.YanP.TaylorK.SchulteisC.et al
